[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condbio:melanoma:nras-gene":3},{"condition":4,"biomarker":5,"total":6,"trials":7},"Melanoma","NRAS Gene",3,[8,16,22],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT07584226","A First-in-human Study of RLY-8161 in Advanced NRAS-Mutant Solid Tumors",[12],"Phase 1","RECRUITING","2026-08-26T02:16:52.995882Z","2026-05-29T15:36:40.197011Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":20,"content_modified":21},"NCT06326411","A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors",[12],"2026-08-26T02:18:13.438956Z","2026-05-05T02:43:27.481677Z",{"nct_id":23,"title":24,"phases":25,"status":13,"updated_at":26,"content_modified":27},"NCT07252479","Evaluation of RAS Inhibitor Treatment in Participants With Advanced or Metastatic Solid Tumors Harboring RAS Mutations",[12],"2026-08-26T02:16:01.910993Z","2026-06-16T05:54:07.937487Z"]